25R,26-氧胆固醇和一种氧胆固醇合成模拟物抑制了 Varicella zoster 病毒的复制
Andrea Civra1, Matteo Costantino1, Domiziana Porporato2
1Department of Clinical and Biological Sciences, University of Turin, Orbassano, Turin, 10043, Italy.
Antiviral research
|February 15, 2025
概括
新的氧化胆固醇,25R,26-氧胆固醇和PFM067,对疹病毒 (Varicella-zoster Virus,VZV) 显示出抗病毒活性. 这些化合物对VZV斑块和葡萄糖蛋白gE排放有效,也与阿西克洛维尔协同作用.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 麻疹病毒 (Varicella-zoster Virus,简称VZV) 引起水和带状疹,其重新激活会带来风险,特别是在免疫受损的个体中.
- 目前的抗病毒药物向VZVDNA复制,但面临耐药性问题,需要新的治疗策略.
- 氧醇,包括27-胆固醇 (25R,26OHC) 和合成模拟物PFM067,已经显示出对简单疹病毒 (HSV) 的有效性.
研究的目的:
- 评估25-基胆固醇 (25OHC),25R,26OHC和PFM067对VZV的抗病毒潜力.
- 研究这些氧化在VZV感染细胞中的作用机制.
- 评估氧化与现有的VZV治疗方法 (如阿西克洛维尔) 的协同作用.
主要方法:
- 在体外抗病毒测试以确定对VZV的疗效 (EC50) 和斑块减少.
- 分析病毒葡萄糖蛋白gE从cis-Golgi区的输出.
- 与阿西克洛维尔 (ACV) 进行组合研究,以评估协同抗病毒效应.
主要成果:
- 25R,26OHC和PFM067在低微分子EC50值的VZV上表现出抗病毒活性.
- 这些氧醇显著减少了VZV斑块的形成.
- 发现25R,26OHC和PFM067可以抑制VZV糖蛋白gE从cis-Golgi的输出,并与阿西克洛维尔协同作用.
结论:
- 25R,26OHC和PFM067显示出对VZV有前途的抗病毒活性.
- 它们独特的作用机制,抑制病毒的退出,提供了一个新的治疗途径.
- 这些氧化是进一步开发VZV治疗药物的潜在候选者,特别是在组合疗法中.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
512
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
512
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.5K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
513
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
513